Cytosorbents (CTSO) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,974.00 |
| Dec 31, 2025 | -2,991.00 |
| Sep 30, 2025 | -1,527.00 |
| Jun 30, 2025 | 1,440.00 |
| Mar 31, 2025 | 3,067.00 |
| Dec 31, 2024 | 6,129.00 |
| Sep 30, 2024 | 4,614.00 |
| Jun 30, 2024 | 951.00 |
| Mar 31, 2024 | -1,023.00 |
| Dec 31, 2023 | -2,907.00 |
| Sep 30, 2023 | -2,794.00 |
| Jun 30, 2023 | -1,925.00 |
| Mar 31, 2023 | -1,088.00 |
| Dec 31, 2022 | 484.00 |
| Sep 30, 2022 | 345.00 |
| Jun 30, 2022 | 7,170.00 |
| Mar 31, 2022 | 35,162.00 |
| Dec 31, 2021 | 16,267.00 |
| Sep 30, 2021 | 11,616.00 |
| Jun 30, 2021 | 11,227.00 |
| Mar 31, 2021 | 10,808.00 |
| Dec 31, 2019 | 4,690.00 |
| Sep 30, 2019 | -4,292.00 |
| Jun 30, 2019 | -2,243.00 |
| Mar 31, 2019 | 2,555.00 |
| Dec 31, 2018 | 42,513.00 |
| Sep 30, 2018 | 97,226.00 |
| Jun 30, 2018 | 60,587.00 |
| Mar 31, 2018 | 14,703.00 |
| Dec 31, 2017 | 22,020.00 |
| Sep 30, 2017 | 29,750.00 |
| Jun 30, 2017 | 67,856.00 |
| Mar 31, 2017 | 174,935.00 |
| Dec 31, 2016 | 25,183.00 |
| Sep 30, 2016 | 8,324.00 |